Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final results.

Zeuzem S, Asselah T, Angus P, Zarski JP, Larrey D, Müllhaupt B, Gane E, Schuchmann M, Lohse AW, Pol S, Bronowicki JP, Roberts S, Arasteh K, Zoulim F, Heim M, Stern JO, Nehmiz G, Kukolj G, Böcher WO, Mensa FJ.

Open source

DOI: 10.3851/imp2567
Published: 2013-04-04
Container: Antivir Ther
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3851/imp2567,
  title = {Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final results.},
  author = {Zeuzem S and  Asselah T and  Angus P and  Zarski JP and  Larrey D and  Müllhaupt B and  Gane E and  Schuchmann M and  Lohse AW and  Pol S and  Bronowicki JP and  Roberts S and  Arasteh K and  Zoulim F and  Heim M and  Stern JO and  Nehmiz G and  Kukolj G and  Böcher WO and  Mensa FJ.},
  year = {2013},
  journal = {Antivir Ther},
  doi = {10.3851/imp2567},
  url = {https://doi.org/10.3851/imp2567}
}

RIS

TY  - JOUR
TI  - Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final results.
AU  - Zeuzem S
AU  -  Asselah T
AU  -  Angus P
AU  -  Zarski JP
AU  -  Larrey D
AU  -  Müllhaupt B
AU  -  Gane E
AU  -  Schuchmann M
AU  -  Lohse AW
AU  -  Pol S
AU  -  Bronowicki JP
AU  -  Roberts S
AU  -  Arasteh K
AU  -  Zoulim F
AU  -  Heim M
AU  -  Stern JO
AU  -  Nehmiz G
AU  -  Kukolj G
AU  -  Böcher WO
AU  -  Mensa FJ.
PY  - 2013
JO  - Antivir Ther
DO  - 10.3851/imp2567
UR  - https://doi.org/10.3851/imp2567
ER  -

APA

S, Z., T, A., P, A., JP, Z., D, L., B, M., E, G., M, S., AW, L., S, P., JP, B., S, R., K, A., F, Z., M, H., JO, S., G, N., G, K., WO, B., & FJ., M. (2013). Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final results.. Antivir Ther. https://doi.org/10.3851/imp2567

Source records

europe-pmc · retrieved 2026-09-27T05:49:22.620Z
hal · retrieved 2026-09-27T05:49:22.643Z